F-star Therapeutics, Inc. FSTX
Trading inactive
| Déclarant | Citoyenneté ou lieu d'organisation | Pouvoir de vote unique | Pouvoir de vote partagé | Pouvoir de disposition unique | Pouvoir de disposition partagé | Montant en propriété effective | Pourcentage détenu | Date d'achat |
|---|---|---|---|---|---|---|---|---|
| Beryl Capital Partners II LP | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 17/03/2023 |
| Beryl Capital Management LP | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 17/03/2023 |
| Beryl Capital Management LP | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 17/03/2023 |
| Beryl Capital Management LLC | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 17/03/2023 |
| Beryl Capital Partners II LP | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 17/03/2023 |
| David A. Witkin | U.S.A. | 0 | 0 | 0 | 0 | 0 | 0 % | 17/03/2023 |
| Beryl Capital Management LLC | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 17/03/2023 |
| David A. Witkin | U.S.A. | 0 | 0 | 0 | 0 | 0 | 0 % | 17/03/2023 |
| Ridgeback Capital Management LLC | Delaware | 0 | 52509 | 0 | 52509 | 52509 | 0.2 % | 14/02/2023 |
| Ridgeback Capital Investments LLC | Delaware | 0 | 52509 | 0 | 52509 | 52509 | 0.2 % | 14/02/2023 |
| Ridgeback Capital Investments L.P. | Delaware | 0 | 52509 | 0 | 52509 | 52509 | 0.2 % | 14/02/2023 |
| Ridgeback Capital Investments LLC | Delaware | 0 | 52509 | 0 | 52509 | 52509 | 0.2 % | 14/02/2023 |
| Ridgeback Capital Investments L.P. | Delaware | 0 | 52509 | 0 | 52509 | 52509 | 0.2 % | 14/02/2023 |
| Ridgeback Capital Management LLC | Delaware | 0 | 52509 | 0 | 52509 | 52509 | 0.2 % | 14/02/2023 |
| Ridgeback Capital Management LLC | Delaware | 0 | 1834360 | 0 | 1834360 | 1834360 | 8.9 % | 14/02/2022 |
| Ridgeback Capital Investments L.P. | Delaware | 0 | 1834360 | 0 | 1834360 | 1834360 | 8.9 % | 14/02/2022 |
| Ridgeback Capital Investments LLC | Delaware | 0 | 1834360 | 0 | 1834360 | 1834360 | 8.9 % | 14/02/2022 |
| Atlas Venture Associates Opportunity I, L.P. | Delaware | 0 | 599524 | 0 | 599524 | 599524 | 2.9 % | 11/02/2022 |
| Atlas Venture Opportunity Fund I, L.P. | Delaware | 0 | 599524 | 0 | 599524 | 599524 | 2.9 % | 11/02/2022 |
| Atlas Venture Associates Opportunity I, LLC | Delaware | 0 | 599524 | 0 | 599524 | 599524 | 2.9 % | 11/02/2022 |
| Point72 Capital Advisors, Inc. | Delaware | 0 | 1100000 | 0 | 1100000 | 1100000 | 5.7 % | 18/05/2021 |
| Steven A. Cohen | United States | 0 | 1100000 | 0 | 1100000 | 1100000 | 5.7 % | 18/05/2021 |
| Steven A. Cohen | United States | 0 | 1100000 | 0 | 1100000 | 1100000 | 5.7 % | 18/05/2021 |
| Point72 Capital Advisors, Inc. | Delaware | 0 | 1100000 | 0 | 1100000 | 1100000 | 5.7 % | 18/05/2021 |
| Point72 Asset Management, L.P. | Delaware | 0 | 1100000 | 0 | 1100000 | 1100000 | 5.7 % | 18/05/2021 |
| Point72 Asset Management, L.P. | Delaware | 0 | 1100000 | 0 | 1100000 | 1100000 | 5.7 % | 18/05/2021 |
| Rock Springs Capital LLC | Delaware | 0 | 1054232 | 0 | 1054232 | 0 | 5.73 % | 17/05/2021 |
| Rock Springs Capital Master Fund LP | Cayman Islands | 0 | 1000000 | 0 | 1000000 | 0 | 5.44 % | 17/05/2021 |
| Rock Springs Capital LLC | Delaware | 0 | 1054232 | 0 | 1054232 | 0 | 5.73 % | 17/05/2021 |
| Rock Springs Capital Management LP | Delaware | 0 | 1054232 | 0 | 1054232 | 0 | 5.73 % | 17/05/2021 |
| Rock Springs Capital Master Fund LP | Cayman Islands | 0 | 1000000 | 0 | 1000000 | 0 | 5.44 % | 17/05/2021 |
| Rock Springs Capital Management LP | Delaware | 0 | 1054232 | 0 | 1054232 | 0 | 5.73 % | 17/05/2021 |
| Boxer Capital, LLC | Delaware | 0 | 1501428 | 0 | 1501428 | 1501428 | 8.2 % | 17/05/2021 |
| Joe Lewis | United Kingdom | 0 | 1501428 | 0 | 1501428 | 1501428 | 8.2 % | 17/05/2021 |
| Boxer Asset Management Inc. | Bahamas | 0 | 1501428 | 0 | 1501428 | 1501428 | 8.2 % | 17/05/2021 |
| Boxer Capital, LLC | Delaware | 0 | 1501428 | 0 | 1501428 | 1501428 | 8.2 % | 17/05/2021 |
| Joe Lewis | United Kingdom | 0 | 1501428 | 0 | 1501428 | 1501428 | 8.2 % | 17/05/2021 |
| Boxer Asset Management Inc. | Bahamas | 0 | 1501428 | 0 | 1501428 | 1501428 | 8.2 % | 17/05/2021 |
| Ridgeback Capital Investments LLC | Delaware | 0 | 494360 | 0 | 494360 | 494360 | 5.4 % | 09/04/2021 |
| Ridgeback Capital Management LLC | Delaware | 0 | 494360 | 0 | 494360 | 494360 | 5.4 % | 09/04/2021 |
| Ridgeback Capital Investments L.P. | Delaware | 0 | 494360 | 0 | 494360 | 494360 | 5.4 % | 09/04/2021 |
| Ridgeback Capital Management LLC | Delaware | 0 | 407567 | 0 | 407567 | 407567 | 4.5 % | 16/02/2021 |
| Ridgeback Capital Investments L.P. | Delaware | 0 | 407567 | 0 | 407567 | 407567 | 4.5 % | 16/02/2021 |
| Ridgeback Capital Investments LLC | Delaware | 0 | 407567 | 0 | 407567 | 407567 | 4.5 % | 16/02/2021 |
| Atlas Venture Associates VII, L.P. | Delaware | 0 | 5749961 | 0 | 5749961 | 5749961 | 6.3 % | 03/02/2021 |
| Atlas Associates VII, Inc. | Delaware | 0 | 5749961 | 0 | 5749961 | 5749961 | 6.3 % | 03/02/2021 |
| Atlas Venture Fund VII, L.P. | Delaware | 0 | 5749961 | 0 | 5749961 | 5749961 | 6.3 % | 03/02/2021 |
| Atlas Venture Opportunity Fund I, L.P. | Delaware | 0 | 5995241 | 0 | 5995241 | 5995241 | 6.6 % | 03/02/2021 |
| Atlas Venture Associates Opportunity I, LLC | Delaware | 0 | 5995241 | 0 | 5995241 | 5995241 | 6.6 % | 03/02/2021 |
| Atlas Venture Associates Opportunity I, L.P. | Delaware | 0 | 5995241 | 0 | 5995241 | 5995241 | 6.6 % | 03/02/2021 |
| Merck KGaA | Germany | 493710 | 0 | 493710 | 0 | 493710 | 5.4 % | 01/02/2021 |
| Merck Ventures B.V. | The Netherlands | 493710 | 0 | 493710 | 0 | 493710 | 5.4 % | 01/02/2021 |
| Merck B.V. | The Netherlands | 493710 | 0 | 493710 | 0 | 493710 | 5.4 % | 01/02/2021 |
| GlaxoSmithKline plc | England and Wales | 803922 | 0 | 803922 | 0 | 803922 | 8.9 % | 30/11/2020 |
| Oncology Impact Fund | Cayman Islands | 603070 | 0 | 603070 | 0 | 603070 | 3.5 % | 08/04/2020 |
| MPM Oncology Impact Management LP | Delaware | 603070 | 0 | 603070 | 0 | 603070 | 3.5 % | 08/04/2020 |
| MPM Oncology Impact Management GP LLC | Delaware | 603070 | 0 | 603070 | 0 | 603070 | 3.5 % | 08/04/2020 |
| UBS Oncology Impact Fund L.P. | Cayman Islands | 603070 | 0 | 603070 | 0 | 603070 | 3.5 % | 08/04/2020 |
| Ridgeback Capital Investments L.P. | Cayman Islands | 0 | 1142900 | 0 | 1142900 | 1142900 | 6.9 % | 06/01/2020 |
| Ridgeback Capital Investments Ltd. | Cayman Islands | 0 | 1142900 | 0 | 1142900 | 1142900 | 6.9 % | 06/01/2020 |
| Ridgeback Capital Management LP | Delaware | 0 | 1142900 | 0 | 1142900 | 1142900 | 6.9 % | 06/01/2020 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 72232 | 0 | 72232 | 72232 | 0 % | 14/02/2019 |
| Mark N. Lampert | United States | 0 | 951701 | 0 | 951701 | 951701 | 5.8 % | 14/02/2019 |
| BVF Inc. | Delaware | 0 | 951701 | 0 | 951701 | 951701 | 5.8 % | 14/02/2019 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 355132 | 0 | 355132 | 355132 | 2.2 % | 14/02/2019 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 466424 | 0 | 466424 | 466424 | 2.8 % | 14/02/2019 |
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 72232 | 0 | 72232 | 72232 | 0 % | 14/02/2019 |
| BVF Partners L.P. | Delaware | 0 | 951701 | 0 | 951701 | 951701 | 5.8 % | 14/02/2019 |
| Adage Capital Partners, L.P. | Delaware | 0 | 1000000 | 0 | 1000000 | 1000000 | 6.18 % | 18/10/2018 |
| Phillip Gross | United States | 0 | 1000000 | 0 | 1000000 | 1000000 | 6.18 % | 18/10/2018 |
| Adage Capital Advisors, L.L.C. | Delaware | 0 | 1000000 | 0 | 1000000 | 1000000 | 6.18 % | 18/10/2018 |
| Robert Atchinson | United States | 0 | 1000000 | 0 | 1000000 | 1000000 | 6.18 % | 18/10/2018 |
| Adage Capital Partners GP, L.L.C. | Delaware | 0 | 1000000 | 0 | 1000000 | 1000000 | 6.18 % | 18/10/2018 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 53773 | 0 | 53773 | 53773 | 0 % | 14/02/2018 |
| Mark N. Lampert | United States | 0 | 823474 | 0 | 823474 | 823474 | 6.4 % | 14/02/2018 |
| BVF Inc. | Delaware | 0 | 823474 | 0 | 823474 | 823474 | 6.4 % | 14/02/2018 |
| BVF Partners L.P. | Delaware | 0 | 823474 | 0 | 823474 | 823474 | 6.4 % | 14/02/2018 |
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 53773 | 0 | 53773 | 53773 | 0 % | 14/02/2018 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 258955 | 0 | 258955 | 258955 | 2 % | 14/02/2018 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 399 | 0 | 399 | 399 | 3.1 % | 14/02/2018 |
| expressly disclaim status as a "group" for purposes of this Schedule 13G. 1. Name of Reporting Persons MPM Oncology Impact Management GP LLC | Delaware | 1436909 | 0 | 1436909 | 0 | 1436909 | 10.6 % | 06/02/2018 |
| expressly disclaim status as a "group" for purposes of this Schedule 13G. 1. Name of Reporting Persons MPM Oncology Impact Management LP | Delaware | 1436909 | 0 | 1436909 | 0 | 1436909 | 10.6 % | 06/02/2018 |
| expressly disclaim status as a "group" for purposes of this Schedule 13G. 1. Name of Reporting Persons Oncology Impact Fund | Cayman Islands | 1436909 | 0 | 1436909 | 0 | 1436909 | 10.6 % | 06/02/2018 |
| UBS Oncology Impact Fund L.P. | Cayman Islands | 1436909 | 0 | 1436909 | 0 | 1436909 | 10.6 % | 06/02/2018 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 304513 | 0 | 304513 | 304513 | 2.4 % | 11/08/2017 |
| Mark N. Lampert | United States | 0 | 652676 | 0 | 652676 | 652676 | 5.1 % | 11/08/2017 |
| BVF Inc. | Delaware | 0 | 652676 | 0 | 652676 | 652676 | 5.1 % | 11/08/2017 |
| BVF Partners L.P. | Delaware | 0 | 652676 | 0 | 652676 | 652676 | 5.1 % | 11/08/2017 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 53773 | 0 | 53773 | 53773 | 0 % | 11/08/2017 |
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 53773 | 0 | 53773 | 53773 | 0 % | 11/08/2017 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 195978 | 0 | 195978 | 195978 | 1.5 % | 11/08/2017 |
| expressly disclaim status as a “group” for purposes of this Schedule 13G. 1. Name of Reporting Persons MPM Oncology Impact Management GP LLC | Delaware | 603070 | 0 | 603070 | 0 | 603070 | 6.4 % | 05/12/2016 |
| expressly disclaim status as a “group” for purposes of this Schedule 13G. 1. Name of Reporting Persons Oncology Impact Fund (Cayman) Management L.P. | Cayman Islands | 603070 | 0 | 603070 | 0 | 603070 | 6.4 % | 05/12/2016 |
| expressly disclaim status as a “group” for purposes of this Schedule 13G. 1. Name of Reporting Persons MPM Oncology Impact Management LP | Delaware | 603070 | 0 | 603070 | 0 | 603070 | 6.4 % | 05/12/2016 |
| UBS Oncology Impact Fund L.P. | Cayman Islands | 603070 | 0 | 603070 | 0 | 603070 | 6.4 % | 05/12/2016 |
| expressly disclaim status as a “group” for purposes of this Schedule 13G. 1. Name of Reporting Persons Ansbert Gadicke | United States | 603070 | 0 | 603070 | 0 | 603070 | 6.4 % | 05/12/2016 |
| Susan Lutz Ross Family Insurance Trust | Delaware | 0 | 15762 | 0 | 15762 | 15762 | 0.2 % | 05/12/2016 |
| The E. Burke Ross, Jr. Descendants’ GST Investment Trust 2014 | Delaware | 0 | 0 | 0 | 0 | 576243 | 6.1 % | 05/12/2016 |
| Peter Lacaillade Jr. | United States | 724848 | 15762 | 724848 | 15762 | 740610 | 7.9 % | 05/12/2016 |
| The E. Burke Ross, Jr. Descendants’ GST Insurance Trust | Delaware | 0 | 0 | 0 | 0 | 148605 | 1.6 % | 05/12/2016 |
| Olivia Lutz Insurance Trust 2014 | Delaware | 0 | 8333 | 0 | 8333 | 8333 | 0.1 % | 16/09/2016 |
| Olivia Lutz Trust 2014 | Delaware | 0 | 7429 | 0 | 7429 | 7429 | 0.1 % | 16/09/2016 |
| The E. Burke Ross, Jr. Descendants’ GST Insurance Trust | Delaware | 0 | 0 | 0 | 0 | 148605 | 1.9 % | 16/09/2016 |
| Peter Lacaillade Jr. | United States | 671938 | 15762 | 671938 | 15762 | 687700 | 8.9 % | 16/09/2016 |
| The E. Burke Ross, Jr. Descendants’ GST Investment Trust 2014 | Delaware | 0 | 0 | 0 | 0 | 523333 | 6.8 % | 16/09/2016 |